Wellvone
Wellvone is a medicine authorised by Swissmedic under authorisation number 53563. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 29 May 1996 and the authorisation is valid without a time limit. ATC code P01AX06 places the medicine in the group Antiprotozoals.
| Authorisation number | 53563 |
|---|---|
| Name | Wellvone |
| Full name | Wellvone, Suspension |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | P01AX06 |
| First authorisation | 29 May 1996 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Wellvone, Suspension | A | 29 May 1996 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 15 | 210 | ml | P01AX06 | 08.04.3. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Wellvone authorised in Switzerland?
Yes. Wellvone is authorised by Swissmedic under authorisation number 53563, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Wellvone have?
Wellvone is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Wellvone?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.